Tackling Tough-To-Treat Patients As HCV Cure Rates Near 100%

It's no longer a matter of which company will achieve the highest hepatitis C cure rates first, but which one will most effectively treat patients who fall through the cracks, since Gilead Sciences Inc., Merck & Co. Inc. and AbbVie Inc.'s latest antiviral drug cocktails cure nearly all patients.